Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auranofin Clinical Trial for Desmoid (ACTD)
jRCTs041210071Completed
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of auranofin in aggressive fibromatosis (AF). Primary endpoint: Progression-free survival. Started Oct 2021; status: completed.
02
Drugs
auranofin
03
Conditions
aggressive fibromatosis (AF)
Beyond the preview
Go deeper on jRCTs041210071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041210071.